Standard BioTools Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript
This is Paul Knight at KeyBanc. I'm the life science analyst covering life science tools industry. Today, we have Standard BioTools presenting. I've gotten to know Michael Egholm and his team over the last year or more. Michael will go into his background, but a long history in the life science industry.
Also, Scott Greenstone is with us today, the Investor Relations Head. But the format is that we have Michael doing a presentation, then we'll open it up for Q&A. You can do the questions through a chat link on your screen or just e-mail me at [email protected].
So with that, Michael, I'll let you start with the overview.
Thank you, Paul, and really appreciate the opportunity to present on Standard BioTools.
I will be making forward-looking statements, so I'm required to show you this slide.
And now that I've done that, the opportunity and the problem we are solving at Standard BioTools is that there are many
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |